Issues Facing the New FDA Commissioner
The new commissioner of the US Food and Drug Administration (FDA), Scott Gottlieb, will have a full plate of issues
Read More
Part D/Prescription Drugs
Senate Committee Advances FDA User Fee Reauthorization Bill with Two Additional Amendments
On Thursday, the bill that would reauthorize the pharmaceutical, medical device, generic drug and biosimilar user fee agreements that would
Read MoreSanofi pledges to keep price hikes below healthcare inflation rate: 4 things to know
(By Mackenzie Bean for Becker’s Hospital Review) Paris-based Sanofi is the latest drugmaker vowing to limit U.S. drug price hikes, reports Financial
Read MoreNearly 1 In 3 Recent FDA Drug Approvals Followed By Major Safety Actions
(By Sydney Lupkin for Kaiser Health News) The Food and Drug Administration is under pressure from the Trump administration to
Read MoreBlue Cross member plans spent 73% more on drugs in 2016 than 2010
(By Mackenzie Bean for Becker’s Hospital Review) The Blue Cross Blue Shield Association on Wednesday issued a report detailing a
Read MoreStudy Results: No Long-Term Benefits of Opioid Medications for Chronic Back Pain
In a first-of-its-kind research at the Minneapolis VA has found no long-term benefits for patients taking opioid medications for chronic
Read MoreMeasuring Drug Impairment In Drivers Is Easier Said Than Done
(By Katherine Hobson for NPR) Drug-impaired driving is a growing concern for highway safety officials. But, as a recent report
Read MoreDrug Coverage Denied By Medicare? How Seniors Can Fight Back
(By Judith Graham for Kaiser Health News) Kenneth Buss had taken Xarelto, a blood thinner, for more than a year
Read MoreMedicare premiums and IRMAA–An Example of Benefits Means Testing
With the current rhetoric building on means testing for Social Security, it’s meaningful to remember that Medicare is already subjected
Read MoreIn small Alzheimer’s study, hints of modest benefit from unusual drug
(By Sharon Begley for STAT) A little-known drug company announced modestly encouraging results for its experimental Alzheimer’s drug on Monday, a
Read More